About Navitas Life Sciences

Navitas Life Sciences is a technology-backed global clinical research organization, headquartered in Princeton, NJ, with over 1000 employees and spread across 5 countries.
At Navitas Life Sciences, we are committed to accelerate time to market for life-saving therapies. We are a technology-driven CRO with end-to-end and point services and solutions for drug development and beyond. We provide outsourced data science, regulatory & safety, and full-service CRO services to large and mid-sized biopharmaceutical clients. Navitas Clinical Research provides full service CRO offerings to global biopharma companies. Navitas Data Sciences is our global clinical data functional service provider.
Our services are backed by a deep understanding of the industry and an expert knowledge of technology. We have built bespoke technology solutions for the most critical industry problems, including our flagship products pharmaREADY and traceREADY.
Our functional service expertise optimizes the clinical trial process, drives cost efficiencies for our clients, and ensures adherence to regulatory compliance requirements. Navitas Life Sciences’ industry-focused consulting services enable our clients to build innovative and sustainable processes, systems & organizations. For over 20 years our industry-leading networks bring together top companies worldwide and shape the future of the industry.
We pride ourselves on being flexible, innovative, reliable, and passionate. Motivated by the success of our clients, we thrive on working together as partners across geographies, time zones, and cultures.
Navitas Life Sciences is proud to be an HIG Portfolio company.

website icon
Website
employees icon
Employees
industry icon
Industry
Research Services
location icon
Headquarter
502 Carnegie Center, Suite 102, Princeton, New Jersey 08540, US
description icon
Founded
2015
description icon
Keywords
Regulatory Consulting, Non-Interventional Studies, Data Aggregation, Clinical Consulting, Risk-Based Monitoring, Virtual Clinical Trials, Pv Consulting, Ba/Be Studies, Argus/Aris-G Implementation, Data Management & Bio-Stats, End-To-End Labelling, Full-Service Clinical Trials (P1-4), Idmp Suite, Investigator Payments, Pv Services, Regulatory Submissions And Lifecycle Management, Incl. Biosimilars, Remote Clinical Trials

Navitas Life Sciences Alternatives

Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
Pharmaceuticals
Industry
Pharmaceuticals
Industry
Pharmaceuticals

Frequently Asked Questions about Navitas Life Sciences

Who is the CEO of Navitas Life Sciences?

Shafiq is the CEO of Navitas Life Sciences. To contact Shafiq email at [email protected] or [email protected].

Who are the decision makers in Navitas Life Sciences?

The decision makers in Navitas Life Sciences are Shafiq, Mallikaarjunan R, Manju Thomas, etc. Click to Find Navitas Life Sciences decision makers emails.

What types of clinical trials does Navitas Life Sciences support?

Navitas Life Sciences offers a comprehensive range of clinical trial services, including full-service clinical trials across all phases (Phase 1 to Phase 4). We specialize in various areas such as non-interventional studies, risk-based monitoring, and virtual clinical trials. Our expertise extends to biosimilars and we provide end-to-end labeling services to ensure compliance and accuracy throughout the trial process.

How does Navitas Life Sciences ensure data integrity and compliance in clinical trials?

At Navitas Life Sciences, we prioritize data integrity and compliance through robust data management and biostatistics practices. Our risk-based monitoring approach allows us to identify and mitigate potential issues proactively. Additionally, we adhere to rigorous regulatory standards and guidelines, ensuring that all data collected during trials is accurate, reliable, and compliant with industry regulations.

What is the role of regulatory consulting in the services offered by Navitas Life Sciences?

Regulatory consulting at Navitas Life Sciences involves providing expert guidance on regulatory submissions and lifecycle management. Our team assists clients in navigating complex regulatory environments, ensuring that their products meet all necessary requirements for approval. This includes support for biosimilars, where we help clients understand the specific regulatory pathways and documentation needed for successful submission.

Can Navitas Life Sciences assist with pharmacovigilance (PV) services?

Yes, Navitas Life Sciences offers comprehensive pharmacovigilance (PV) services. Our PV consulting includes monitoring and managing the safety of pharmaceutical products throughout their lifecycle. We provide solutions for adverse event reporting, risk assessment, and compliance with regulatory requirements, ensuring that our clients maintain the highest standards of patient safety.

What industries does Navitas Life Sciences serve?

Navitas Life Sciences serves a diverse range of industries within the life sciences sector, including pharmaceuticals, biotechnology, and medical devices. Our expertise allows us to support clients across various therapeutic areas, providing tailored solutions that meet the unique challenges of each industry. We are committed to advancing healthcare through innovative research and development.

How does Navitas Life Sciences approach virtual clinical trials?

Navitas Life Sciences embraces the future of clinical research with our virtual clinical trials approach. We leverage technology to enhance patient engagement and streamline data collection, allowing for remote participation in trials. This model increases accessibility for patients and can lead to faster recruitment and retention rates, ultimately accelerating the development of new therapies while maintaining rigorous scientific standards.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more